{"slug":"is-mass-tort-marketing-agency-worth-it","title":"Is Mass Tort Marketing Agency Worth It in 2026? An Honest Cost and ROI Analysis","seoTitle":"Is a Mass Tort Marketing Agency Worth It in 2026?","description":"When hiring a mass tort marketing agency pays off in 2026 and when it doesn't: real payout timelines, cost per signed case, a break-even model and five readiness tests.","banner":"/images/blog-content/is-mass-tort-marketing-agency-worth-it/hero.jpg","ogImage":"/images/og/is-mass-tort-marketing-agency-worth-it-og.jpg","url":"https://www.masstortmarketingagency.com/blogs/is-mass-tort-marketing-agency-worth-it","published":"2026-11-11","modified":"2026-11-11","author":{"name":"MTMA Editorial Team","role":"Mass Tort Marketing Agency"},"keywords":["is mass tort marketing agency worth it","is a mass tort marketing agency worth it","mass tort marketing roi","mass tort marketing cost","mass tort advertising worth it","cost per signed retainer","mass tort marketing agency 2026","is mass tort marketing profitable"],"blocks":[{"type":"quote","text":"**Quick answer.** A mass tort marketing agency is worth it in 2026 only for a plaintiff firm that can fund campaigns for years before fees arrive, answer and work up claimants quickly, absorb torts that fail, choose dockets at the right stage, and judge results by cost per signed and accepted case rather than cost per lead. Large MDL settlements have taken roughly 2.5 to 8 years from consolidation. Firms failing those tests usually do better referring cases out, buying leads on strict terms, or staying in single-event PI."},{"type":"paragraph","text":"**Key takeaways**"},{"type":"list","ordered":false,"items":["**Mass torts are a large, crowded market.** The [JPML's November 2, 2026 report](https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-November-2-2026.pdf) lists 164 active MDL dockets with 204,987 actions pending.","**Money arrives late.** 3M's earplug MDL was created in April 2019 and the company [agreed to a $6.0 billion settlement](https://news.3m.com/2023-08-29-3M-Announces-Combat-Arms-Settlement) on August 29, 2023, payable between 2023 and 2029.","**Some claims never pay.** By March 2024, [more than 41,000 of over 293,000 earplug claims](https://investors.3m.com/news-events/press-releases/detail/1833/combat-arms-earplugs-settlement-moves-to-final-resolution) had been dismissed by the courts, about 14% by our calculation.","**Fee caps can be low.** The DOJ's position is that [FTCA fee caps of 20% and 25%](https://www.justice.gov/d9/2023-10/2023.10.27%20%5B34%5D%20SOI%20re%20Atty%20Fees.pdf) apply to Camp Lejeune claims.","**Common-benefit assessments come off the top.** Philips CPAP [Pretrial Order No. 24](https://www.pawd.uscourts.gov/sites/pawd/files/3014_Pretrial_Order_24.pdf) set a 10% assessment: 8% for fees and 2% for expenses.","**Cost per signed retainer is the number to watch.** Mass Tort Marketing Agency's [published 2026 estimates](/benchmarks) run from $1,800 to $15,000 depending on the tort; no independent source publishes this figure.","**Phone mistakes are expensive.** The TCPA allows [$500 per violation, up to $1,500 if willful](https://www.law.cornell.edu/uscode/text/47/227), and the FCC's one-to-one consent rule was vacated in January 2025."]},{"type":"paragraph","text":"Most answers to this question stop at \"it depends.\" That is true, but a managing partner deciding whether to commit $25,000 or more a month needs to know what it depends on, with numbers. This guide lays out what an agency sells, how ad spend turns into a paid fee, how long that takes in real dockets, where the money leaks, and a break-even model you can run with your own inputs."},{"type":"paragraph","text":"Disclosure: Mass Tort Marketing Agency, a plaintiff-side marketing agency, publishes this page, and a dedicated section near the end assesses us by the same tests we ask you to apply to everyone else. Facts were checked on November 11, 2026. Legal sections are general information, not legal advice."},{"type":"heading","level":2,"text":"The short answer: when a mass tort marketing agency is worth it"},{"type":"paragraph","text":"Hiring a mass tort marketing agency is worth it when your firm can carry several years of negative cash flow, process claimants fast, and treat each tort as one bet in a portfolio. It is usually not worth it when the firm needs the money back within a year, has no intake depth, or plans to judge the program on cost per lead."},{"type":"paragraph","text":"The category itself is not the problem. Agencies buy media, write creative, build landing pages, screen callers and hand over leads or signed cases. Those are real services with real costs. The trouble is that the return on those services depends mostly on things the agency does not control: whether the litigation succeeds, how long it takes, how many of your claimants survive the defense's challenges, and how much of the fee goes to common-benefit funds or co-counsel."},{"type":"paragraph","text":"That is why two firms can hire the same agency, run the same tort in the same month, and reach opposite conclusions. One has the cash and the intake staff to sign, work up and hold several hundred cases until a settlement program opens. The other runs out of patience, or credit, around month nine and walks away with a docket it cannot afford to finish."},{"type":"table","header":["Usually worth it if","Usually not worth it if"],"rows":[["You can fund spend for 3+ years before fees","You need payback inside 12 months"],["Intake answers calls 24/7 and collects records","Calls go to voicemail after hours"],["You run several torts as a portfolio","One tort carries the whole bet"],["You judge cost per signed and accepted case","You judge cost per lead"],["You join torts after MDL creation and early science","You chase the newest tort before any court action"],["Your contracts give you data and ad account access","The vendor owns the claimants and the accounts"]]},{"type":"paragraph","text":"These are rules of thumb, not data. They come from the payout timelines, attrition examples and fee structures documented later in this guide."},{"type":"heading","level":3,"text":"Who tends to get value"},{"type":"paragraph","text":"In my view, three kinds of firms get the most from an agency. The first is an established mass tort firm that already litigates in one or more MDLs, has records retrieval and fact-sheet staff, and wants more claimants without building a media team. The second is a well-funded PI firm adding mass torts as a second line, with a partner who owns the portfolio and a budget set aside as long-term capital. The third is a firm that plans to refer out or co-counsel most cases but wants its own claimant relationships rather than buying signed retainers from someone else."},{"type":"heading","level":3,"text":"Who usually loses money"},{"type":"paragraph","text":"The firms that tend to lose are those that treat a mass tort campaign like a car accident campaign. Car accident cases often resolve within months, so cost per lead and cost per sign-up are reasonable short-term guides. A mass tort retainer is a claim on a fee that may arrive in 2029 or later, and only if the tort survives. A firm that spends $150,000 in a quarter and then reviews \"ROI\" at the end of that quarter will always see a loss, because nothing has paid yet."},{"type":"paragraph","text":"The other losers are firms that sign whoever calls. A signed retainer that fails product identification, diagnosis or exposure proof costs the same to acquire as a good one, and then costs more again in records fees and staff time before it is dropped. The sections below show how often that happens in real dockets."},{"type":"heading","level":3,"text":"The real question to ask"},{"type":"paragraph","text":"So the better question is narrower: is this agency, on this tort, at this stage of the litigation, at this cost per signed case, worth it for a firm with our cash position and intake capacity? The rest of this guide gives you the parts to answer it."},{"type":"heading","level":2,"text":"What you actually buy from a mass tort marketing agency"},{"type":"paragraph","text":"You buy claimant acquisition: media buying, creative, landing pages, call handling and screening, consent records, delivery into your systems and reporting. You do not buy litigation, a settlement, or any guarantee that a tort will pay, and no ethical agency will sell you those."},{"type":"paragraph","text":"The service list sounds similar across vendors, so the useful work is in the details. Two agencies can both promise \"intake\" while one means a scripted call center that collects a name and phone number, and the other means trained screeners who check diagnosis dates, product use and statute of limitations before a lead reaches you. The difference shows up directly in your cost per signed case."},{"type":"table","header":["Deliverable","What it means","What to confirm in writing"],"rows":[["Media buying","Paid search, social, TV, CTV, programmatic","Who owns the ad accounts and pixels"],["Creative","Ads and scripts for each tort","Who reviews for bar rules before launch"],["Landing pages","Tort-specific pages and forms","Consent language and who stores it"],["Intake and screening","Calls, texts, qualification questions","Hours, languages, criteria used"],["Consent capture","Records of each claimant's consent","Token or record kept for every lead"],["Delivery","Live transfer, CRM posting, e-sign","Speed and which fields are sent"],["Reporting","Spend, leads, qualified, signed","Weekly, per tort, tied to signed cases"],["Replacement terms","Credits for leads that fail criteria","Window, proof needed, how criteria are set"]]},{"type":"heading","level":3,"text":"Media and creative"},{"type":"paragraph","text":"Media buying is the largest cost line in most programs, and the one where ownership matters most. If the agency runs your campaigns inside its own ad accounts, you lose the history, audiences and conversion data the day you leave. Ask for accounts in your firm's name, or at minimum full read access and a written transfer clause."},{"type":"paragraph","text":"Creative is where bar rules bite. [ABA Model Rule 7.1](https://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/rule_7_1_communication_of_a_lawyer_s_services/) bars a \"false or misleading communication about the lawyer or the lawyer's services,\" and some states add drug-ad warnings, covered in the compliance section. Your firm, not the agency, answers to the bar for ads run on your behalf."},{"type":"heading","level":3,"text":"Intake, screening and consent"},{"type":"paragraph","text":"Intake is where most of the money is won or lost. Speed matters because claimants who call about a tort often call more than one number. Screening depth matters because every unqualified signature costs you twice. Consent capture matters because a later TCPA claim will turn on whether you can prove the person asked to be contacted."},{"type":"paragraph","text":"Ask what questions screeners ask for your specific tort, who wrote them, and whether you can change them. The questions should mirror the tort's qualification criteria as your litigation team understands them, not a generic script."},{"type":"heading","level":3,"text":"Delivery and reporting"},{"type":"paragraph","text":"Delivery should put the claimant into your case management system with the full screening record, the consent record and the call recording. Reporting should run weekly and connect spend to signed retainers by tort and by channel. A report that stops at lead counts tells you nothing about whether the program is working."},{"type":"heading","level":3,"text":"What an agency cannot do"},{"type":"paragraph","text":"An agency cannot litigate, choose your co-counsel, guarantee a settlement value, or promise a number of accepted cases. It also cannot share in your fee. [ABA Model Rule 5.4](https://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/rule_5_4_professional_independence_of_a_lawyer/) restricts sharing legal fees with nonlawyers, which is why agencies charge flat monthly fees, per-lead prices or per-retainer prices rather than a percentage of your recovery. Any vendor proposing a cut of case fees is proposing something your bar is likely to treat as a problem."},{"type":"paragraph","text":"For a longer checklist of what to ask before signing, see [how to choose a mass tort marketing agency](/how-to-choose-a-mass-tort-marketing-agency) and the [mass tort marketing buyer's guide](/how-to-choose-a-mass-tort-marketing-agency)."},{"type":"heading","level":2,"text":"The economics: from ad spend to a paid fee"},{"type":"paragraph","text":"An agency's real cost is your total spend divided by the cases that survive to a paid fee, not the leads it delivers. Every stage between the ad and the fee loses cases, and the fee itself is reduced by common-benefit assessments and any co-counsel share before it reaches your firm."},{"type":"image","src":"/images/blog-content/is-mass-tort-marketing-agency-worth-it/01-spend-to-fee-funnel.jpg","alt":"Funnel from ad spend through leads, qualified, signed, accepted and settled cases to a paid fee","caption":"Each stage loses cases. An agency's real cost is the spend divided by the cases that survive to a paid fee, not the leads it delivers."},{"type":"paragraph","text":"Think of the program as a chain of seven links: ad spend, leads, qualified leads, signed retainers, accepted cases, settled cases and paid fees. Most vendor reporting covers the first three or four. The last three happen inside your firm and the courts, often years later, and they decide whether the first four were worth paying for."},{"type":"heading","level":3,"text":"Cost per lead versus cost per signed retainer"},{"type":"paragraph","text":"Cost per lead is the easiest number to quote and the least useful. Mass Tort Marketing Agency's published 2026 estimates put cost per lead at $50 to $500 depending on the tort, and cost per signed retainer at $1,800 to $15,000. Those are our own estimates, not market data: we found no reputable independent source that publishes cost per signed case for mass torts."},{"type":"paragraph","text":"The same post works through a simple illustration. A firm spending $20,000 a month at a $200 cost per lead gets 100 leads. If 12 qualify and 6 sign, the cost per signed retainer is about $3,333, not $200. The lead price looked cheap; the case did not."},{"type":"heading","level":3,"text":"Published estimates by tort"},{"type":"paragraph","text":"Our published estimates vary widely by tort, because qualification rules, claimant age and the records needed all differ:"},{"type":"table","header":["Tort","Published CPSR estimate"],"rows":[["Camp Lejeune","$4,000–$12,000"],["AFFF","$4,000–$10,000"],["Roundup","$3,500–$10,000"],["Hair relaxer","$2,500–$7,500"],["Depo-Provera","$2,500–$7,500"],["Bard PowerPort","$3,500–$9,500"],["Hernia mesh","$3,000–$8,500"],["NEC baby formula","$5,000–$15,000"]]},{"type":"paragraph","text":"Treat these as starting ranges for a conversation with any vendor, ours included. Your own cost per signed retainer will depend on your intake speed, your criteria and your market. For more on how signed-retainer pricing works, see our page on [mass tort signed retainers](/mass-tort-signed-retainers)."},{"type":"heading","level":3,"text":"What each stage costs and loses"},{"type":"table","header":["Stage","What it costs you","How cases are lost"],"rows":[["Ad spend to lead","Media plus management","Wrong audience, weak creative"],["Lead to qualified","Screening time","No diagnosis, no product use, time-barred"],["Qualified to signed","Intake follow-up","Claimant signs elsewhere or stops answering"],["Signed to accepted","Records and staff time","Proof of use or injury missing"],["Accepted to settled","Litigation costs, years of waiting","Expert exclusion, defense verdicts, dismissals"],["Settled to fee paid","Holdbacks and assessments","Common-benefit fees, liens, fee caps"]]},{"type":"paragraph","text":"The first three rows are where an agency can help. The last three are where most of the risk sits, and they are why cost per signed retainer is still only a halfway measure. The better measure is cost per accepted case, then net fee per dollar spent."},{"type":"heading","level":3,"text":"Contingency fees and fee caps"},{"type":"paragraph","text":"Your fee is set by your retainer agreement and by any cap that applies. Fee percentages vary by state, tort and agreement, and we did not find a reliable source for a single \"typical\" mass tort fee, so this guide does not quote one. The clearest documented example is Camp Lejeune, where the DOJ's position is that FTCA caps apply: 20% for administrative settlements and 25% once suit is filed, under [28 U.S.C. § 2678](https://www.govinfo.gov/content/pkg/USCODE-2015-title28/html/USCODE-2015-title28-partVI-chap171-sec2678.htm)."},{"type":"paragraph","text":"That matters because a campaign priced for a higher fee looks very different at 20%. In the break-even model later in this guide, the fee rate is one of the inputs you change first."},{"type":"heading","level":3,"text":"Common-benefit assessments"},{"type":"paragraph","text":"In most large MDLs, the court orders a percentage of each recovery set aside to pay the lawyers who did the shared work: discovery, experts, bellwether trials. These common-benefit assessments come off before your firm is paid."},{"type":"table","header":["Docket","Assessment","Source"],"rows":[["Philips CPAP (MDL 3014)","10%: 8% fees, 2% expenses","Court order, 2022"],["Roundup (MDL 2741)","8% holdback from attorney fees","[Law.com, 2021](https://www.law.com/newyorklawjournal/2021/06/21/judge-grants-roundup-fee-order-despite-totally-out-of-control-mdl-compensation-system/)"],["3M earplug (MDL 2885)","Tiered; later signers paid more","[Common Benefit Order No. 3](https://www.flnd.uscourts.gov/sites/flnd/files/mdl/Common_Benefit_Order_No._3_and_Exhibit_A.pdf)"]]},{"type":"paragraph","text":"The 3M order tied the percentage to when counsel signed the participation agreement, so late joiners paid a higher share. That is a direct cost of entering a tort late. The Roundup judge also refused to extend the 8% holdback to state-court and unfiled cases, so where your cases sit can change the math."},{"type":"paragraph","text":"Common-benefit pools can be large. Law360 reported 3M earplug attorneys were near approval of [\"up to $540M\"](https://law360.com/amp/articles/2261110) in common-benefit payouts. They can also be contested: a Roundup special master's 2025 report [recommended lead counsel receive $0](https://law.com/therecorder/2025/02/05/roundup-special-masters-report-recommends-lead-counsel-get-0-in-common-benefit-fees) in common-benefit fees."},{"type":"heading","level":3,"text":"Putting the chain together"},{"type":"paragraph","text":"Here is the plain-language version of the math. Take the gross award a compensable claimant receives. Multiply by your fee rate. Take off the common-benefit assessment. Take off any share owed to co-counsel. Multiply by the share of signed cases that end up compensable. Subtract your per-case workup costs. What remains, discounted for the years you wait, is the most you can afford to pay per signed retainer. If an agency's cost per signed retainer is higher than that number, the program loses money even if every lead is real."},{"type":"heading","level":2,"text":"The waiting problem: how long mass tort money takes"},{"type":"paragraph","text":"In the large dockets documented below, the gap between MDL creation and a global settlement ran from about 2 years 7 months to almost 8 years, and payments often stretched years beyond the announcement. Your marketing spend happens at the start of that cycle and your fee at the end, so the gap is capital your firm must carry."},{"type":"image","src":"/images/blog-content/is-mass-tort-marketing-agency-worth-it/02-cash-cycle.jpg","alt":"Timeline from campaign spend and intake through bellwether trials and settlement to the fee being paid","caption":"Spending happens at the start and fees arrive at the end, often years apart. The gap is the capital a firm must be able to carry."},{"type":"paragraph","text":"Firms that come from single-event PI often underestimate this. A car accident case might settle in months. A mass tort retainer signed today sits through fact sheets, bellwether trials, appeals, settlement negotiation, participation thresholds and claims administration. Each stage can stall."},{"type":"heading","level":3,"text":"Real timelines from real dockets"},{"type":"paragraph","text":"The table below uses MDL transfer dates from the [JPML's docket list by MDL number](https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_MDL_Number-November-2-2026.pdf) and settlement dates from company releases and court-reporting sources. The \"time to deal\" column is our calculation."},{"type":"table","header":["Tort","MDL created","Settlement announced","Amount","Time to deal"],"rows":[["Philips CPAP","Oct 2021","Apr 2024","$1.1B","about 2 yr 7 mo"],["Roundup (first)","Oct 2016","Jun 2020","Up to $10.9B","about 3 yr 9 mo"],["3M earplugs","Apr 2019","Aug 2023","$6.0B","about 4 yr 5 mo"],["Bard hernia mesh","Aug 2018","Oct 2024","Confidential","about 6 yr 2 mo"],["AFFF (PI claims)","Dec 2018","Nov 2026","$5.8B present value","about 7 yr 11 mo"],["J&J talc","Oct 2016","None","None","10+ years, open"]]},{"type":"paragraph","text":"Sources for each row: Philips' [$1.1 billion settlement](https://ktvz.com/health/cnn-health/2024/04/30/philips-reaches-1-1-billion-settlement-for-cpap-machine-lawsuits-admits-no-fault-or-liability/), with payments expected in 2025; Bayer's [2020 Roundup agreement](https://www.abajournal.com/news/article/bayer-will-pay-up-to-10.9b-to-resolve-roundup-litigation), covering about 125,000 filed and unfiled claims; BD's [hernia mesh settlement](https://www.claimsjournal.com/news/national/2024/10/03/326611.htm) of about 38,000 suits, with the amount kept confidential; and 3M's [AFFF personal injury resolution](https://www.sec.gov/Archives/edgar/data/0000066740/000006674026000318/pressrelease-xnov2026xv2.htm), a \"$5.8 billion present value commitment through 2034.\""},{"type":"heading","level":3,"text":"Announcement is not payment"},{"type":"paragraph","text":"A settlement announcement starts another clock. The 3M earplug deal runs payments from 2023 to 2029, roughly ten years after the MDL was created. The AFFF commitment runs through 2034. Philips announced in April 2024 and expected payments in 2025. Most programs also depend on participation thresholds, lien resolution and claims review before money moves."},{"type":"paragraph","text":"Even after a settlement, inventories linger. The JPML still listed 23,299 Bard hernia mesh actions pending in November 2026, two years after the BD settlement announcement."},{"type":"heading","level":3,"text":"When the deal changes shape"},{"type":"paragraph","text":"Roundup shows how long a tort can stay unsettled even after a large settlement. After the 2020 agreement, Monsanto proposed a second, $7.25 billion nationwide class settlement for non-Hodgkin lymphoma claims, which received [preliminary approval on March 4, 2026](https://www.insurancejournal.com/news/national/2026/03/05/860517.htm). Payouts under that deal range from [$10,000 to $165,000 per claimant](https://www.cp24.com/news/money/2026/09/11/bayer-faces-pivotal-test-of-us725-billion-roundup-settlement-in-missouri-court/), scaled by severity, age and exposure. A final approval hearing was held September 14, 2026, and Bayer [said a decision would come later](https://www.bayer.com/en/litigation-statement/statement-on-class-final-approval-hearing). As of November 11, 2026, we found no final approval ruling."},{"type":"paragraph","text":"In June 2026 the Supreme Court decided *Monsanto Co. v. Durnell*, holding 7–2 that federal law [preempts a state failure-to-warn claim](https://www.mayerbrown.com/en/insights/publications/2026/06/supreme-court-holds-roundup-failure-to-warn-claim-preempted-by-federal-law) based on Roundup's lack of a cancer warning. A firm that signed Roundup claimants in 2017 has now waited nearly a decade through two settlement structures and a Supreme Court ruling that changed the claims' footing."},{"type":"paragraph","text":"J&J talc is the extreme case. Judge Christopher Lopez [dismissed Red River Talc's Chapter 11 case](https://pharmaphorum.com/news/third-time-not-so-lucky-jjs-bid-end-talc-liability) on March 31, 2025, J&J's third failed bankruptcy route, and the talc MDL still had 69,376 pending actions in November 2026, about ten years after transfer."},{"type":"heading","level":3,"text":"The Camp Lejeune clock"},{"type":"paragraph","text":"Camp Lejeune is not an MDL, but it shows the same lag. The CLJA was enacted on August 10, 2022, and the [Navy's claim deadline](https://www.navy.mil/Press-Office/Press-Releases/display-pressreleases/Article/3864302/navy-reminds-potential-claimants-of-the-clja-filing-deadline/) was August 10, 2024. By June 15, 2026, payments for accepted settlements totaled $723,850,000, according to the [government's settlement status report](https://camplejeunecourtinfo.com/wp-content/uploads/June-_2026_Settlement_Report.pdf). That is about 3 years 10 months from enactment, and spread across 408,000 claims it works out to about $1,774 per claim filed, an illustrative figure by our calculation, not an average payment."},{"type":"heading","level":3,"text":"What this means for your capital"},{"type":"paragraph","text":"If your first signed retainers come in month one and the first fees arrive in year four, you are funding at least three years of spend, staff and records costs before any return. If you keep signing cases through that period, the hole gets deeper before it gets shallower. Plan the program as a capital commitment, set a total ceiling, and model it against your firm's other obligations."},{"type":"heading","level":3,"text":"Litigation funding as a bridge"},{"type":"paragraph","text":"Some firms bridge the gap with outside capital. The commercial litigation finance market grew in 2025: Westfleet Advisors counted about [$2.8 billion in new U.S. commitments](https://riskandinsurance.com/litigation-finance-capital-commitments-rebound-23-after-two-year-contraction/), up from $2.3 billion in 2024, across 346 deals and 39 active funders. That data covers commercial funding, not mass torts specifically, and no reliable mass-tort funding total exists."},{"type":"paragraph","text":"Funding has a cost. The funder's return comes out of your fees, and the terms are negotiated privately, so there is no published benchmark rate to plug into a model. The rules are also tightening. Georgia's [SB 69](https://www.dlapiper.com/en/insights/publications/2025/05/georgia-enacts-sweeping-tort-reform) requires funder registration from January 1, 2026, bars funders from controlling litigation and makes funding agreements discoverable. [Five states passed TPLF laws in 2025](https://www.theclm.org/Magazine/articles/the-state-of-tplf/3432). At the federal level, the [Litigation Funding Transparency Act of 2026](https://www.govinfo.gov/app/details/BILLS-119s3826is) has been introduced, not passed, and a proposed tax on funding profits was [dropped from the 2025 reconciliation package](https://news.bloomberglaw.com/business-and-practice/maga-backers-reflect-rare-split-on-regulating-litigation-funders)."},{"type":"paragraph","text":"If you need funding to run a campaign, include its cost as a direct reduction of your net fee in the break-even model, and assume discovery of the agreement is possible."},{"type":"heading","level":2,"text":"Where the money leaks: attrition, dismissals and fee splits"},{"type":"paragraph","text":"Between a signed retainer and a paid fee, cases leak out through failed qualification, incomplete fact sheets, vetting orders, expert rulings and defense wins, and the fee that survives may be split with co-counsel. No one publishes a reliable attrition rate across all mass torts, so the honest approach is to study tort-specific examples and plan for a wide range."},{"type":"paragraph","text":"A [Yale Law Journal Forum essay](https://yalelawjournal.org/essay/nudges-and-norms-in-multidistrict-litigation) notes that no firm data exists on what share of mass tort plaintiffs have invalid claims. Anyone quoting a single industry-wide attrition figure is guessing. What we do have are court filings and company disclosures from specific dockets, and they show how large the leaks can get."},{"type":"table","header":["Docket","What happened","Source type"],"rows":[["3M earplugs","41,000+ of 293,000+ claims dismissed by courts","3M release, 2024"],["3M earplugs","About 20,000 claims dismissed for no proof of service","Court reporting, 2022"],["Camp Lejeune","About 13,000 of 408,000 claims met a minimum documentation screen","DOJ court filing, 2026"],["Camp Lejeune","Of those, more than 88% had insufficient evidence","DOJ court filing, 2026"],["Zantac (federal)","All general-causation experts excluded","Court reporting, 2022"],["NEC (federal)","3 of 4 selected bellwether cases dismissed","Court reporting, 2026"]]},{"type":"heading","level":3,"text":"Qualification failures"},{"type":"paragraph","text":"The most avoidable leak is a claimant who never qualified. In May 2022, about [20,000 earplug claims were dismissed](https://stripes.com/veterans/2022-05-09/military-earplugs-3m-lawsuits-veterans-5949626.html) without prejudice for failure to provide proof of military service. That is a records problem, and much of it could have been caught at intake. 3M also [stated in June 2023](https://news.3m.com/2023-06-09-3M-Reinforces-Preparedness-to-Defend-Combat-Arms-Earplug-Litigation-Docket) that Defense Department records for more than 175,000 plaintiffs showed most had normal hearing. That is the defendant's litigation position, not a finding, but it shows how the defense will test every claimant."},{"type":"paragraph","text":"Camp Lejeune shows the same pattern at a larger scale. Of 408,000 de-duplicated administrative claims, about 13,000 had at least three supporting documents and an Elective Option injury type, about 3.2% by our calculation. Of those, the government's June 2026 filing says \"more than 88% have insufficient evidence to support the claim,\" and less than 2% were sufficiently substantiated."},{"type":"heading","level":3,"text":"Fact sheets and vetting orders"},{"type":"paragraph","text":"Once a case is filed in an MDL, the court usually requires a plaintiff fact sheet and records. Missed deadlines and deficient answers lead to dismissal. Defendants also ask for Lone Pine orders, which require each plaintiff to produce basic proof of exposure and injury early or lose the case. A 2026 vetting order in the thalidomide litigation [required compliance within 90 days or dismissal](https://www.druganddevicelawblog.com/2026/06/case-vetting-order-in-the-thalidomide-litigation.html), according to a defense-side blog. A firm that signs cases faster than it can collect records is building a list of future dismissals."},{"type":"heading","level":3,"text":"Expert rulings and defense wins"},{"type":"paragraph","text":"Some leaks have nothing to do with your intake. On December 6, 2022, the Zantac MDL judge [excluded all of plaintiffs' general-causation experts](https://www.propertycasualty360.com/fcs/2022/12/12/federal-judge-tosses-plaintiffs-experts-eliminating-thousands-of-zantac-lawsuits-423-123608/), ending thousands of federal claims at summary judgment. The JPML now lists 806 Zantac actions pending out of 15,018 historical. That drop reflects settlement, dismissal and remand together, so it is not a dismissal rate, but federal claimants in that docket were left without a federal path."},{"type":"paragraph","text":"State court told a different story. GSK agreed in October 2024 to pay [up to $2.2 billion to resolve about 80,000 state-court Zantac cases](https://www.insurancejournal.com/news/national/2024/10/10/796579.htm), mostly in Delaware, and Sanofi and Pfizer [settled thousands more](https://news.bloomberglaw.com/health-law-and-business/gsk-to-settle-80-000-zantac-cases-for-up-to-2-2-billion) earlier that year. Where a case was filed mattered as much as the facts."},{"type":"paragraph","text":"NEC infant formula shows how volatile trial results are. Juries returned $60 million against Mead Johnson, [$495 million and later $70 million against Abbott](https://www.insurancejournal.com/news/national/2026/04/13/865692.htm), with a defense verdict in between, while the federal judge dismissed three of four selected bellwethers. On June 12, 2026, the Illinois Fifth District Appellate Court [reversed the $60 million verdict](https://ilcourtsaudio.blob.core.windows.net/antilles-resources/resources/9cd8c686-8569-40a5-8590-d73888ea51d2/Watson%20v.%20Mead%20Johnson%20Company%202026%20IL%20App%20%285th%29%20240936.pdf) and ordered a new trial."},{"type":"heading","level":3,"text":"Low values inside a settlement"},{"type":"paragraph","text":"Even within a working settlement program, values can be far lower than marketing materials suggest. Three Camp Lejeune Track 1 bellwether cases settled for $10,000, $24,000 and $405. At the other end, the [DOJ reported in March 2026](https://www.justice.gov/opa/pr/department-justice-approves-historic-number-settlements-camp-lejeune-victims-and-families) that Elective Option payments range from $100,000 to $550,000, and that it had approved 2,531 EO offers totaling about $708 million since 2023. The spread between those numbers is the spread your model has to survive."},{"type":"heading","level":3,"text":"Fee splits with co-counsel"},{"type":"paragraph","text":"Many firms that buy mass tort cases do not litigate them alone. They refer them to, or co-counsel with, a firm that does. Under [ABA Model Rule 1.5(e)](https://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/rule_1_5_fees/), a fee division between lawyers in different firms \"may be made only if\" the division is proportional to services performed or each lawyer assumes joint responsibility, the client agrees in writing to the arrangement including each lawyer's share, and the total fee is reasonable. States vary; Maine, for example, omits the proportionality requirement."},{"type":"paragraph","text":"The split itself is negotiated, and there is no published standard. Whatever share you give up comes straight out of the net fee that pays for your marketing. A firm that pays full price for acquisition and then gives away a large part of the fee has to be very confident in the tort. This is general information, not legal advice; check your own state's version of Rule 1.5 before agreeing to a division."},{"type":"heading","level":2,"text":"A break-even model you can run yourself"},{"type":"paragraph","text":"The highest cost per signed retainer your firm can afford equals the net fee you expect from each signed case, after attrition, fee rate, common-benefit assessment, co-counsel share and workup costs, discounted for the years you wait. The worked example below is entirely hypothetical; replace every input with your own."},{"type":"paragraph","text":"The inputs are anchored to sourced ranges so they are plausible, but they are not data about any real firm or campaign. Change them and the answer changes, which is the point."},{"type":"heading","level":3,"text":"The formula in words"},{"type":"paragraph","text":"Break-even cost per signed retainer = (gross award per compensable claimant × share of signed cases that become compensable × your fee rate × (1 − common-benefit assessment) × (1 − co-counsel share)) ÷ discount factor for the wait − workup cost per signed case."},{"type":"paragraph","text":"The discount factor is (1 + your annual cost of capital) raised to the power of (months to payment ÷ 12). Your cost of capital is your firm's own figure, such as the interest rate on its credit line or the return it expects from other uses of the cash. We use 12% below as a hypothetical rate, not a market rate."},{"type":"heading","level":3,"text":"Hypothetical worked example"},{"type":"table","header":["Hypothetical input","Value","Anchor"],"rows":[["Monthly program spend","$25,000","Our published floor per tort"],["Months of spend","6","Hypothetical test length"],["Cost per signed retainer","$5,000","Inside our published $1,800–$15,000 range"],["Attrition before compensation","35%","Between 3M's ~14% and Camp Lejeune extremes"],["Gross award per compensable claimant","$150,000","Inside Roundup class and CLJA EO ranges"],["Fee rate","25%","CLJA cap once suit is filed"],["Common-benefit assessment","8% of fee","Roundup holdback"],["Co-counsel share","0%","Firm litigates its own cases"],["Workup cost per signed case","$2,500","Hypothetical; no verified figure"],["Months from signing to payment","54","Near 3M's MDL-to-deal gap"],["Annual cost of capital","12%","Hypothetical firm rate"]]},{"type":"paragraph","text":"Now the arithmetic, row by row, so you can redo it:"},{"type":"table","header":["Hypothetical calculation","Arithmetic","Result"],"rows":[["Total spend","$25,000 × 6","$150,000"],["Signed retainers","$150,000 ÷ $5,000","30"],["Compensable cases","30 × (1 − 0.35)","19.5"],["Gross awards","19.5 × $150,000","$2,925,000"],["Gross fee","$2,925,000 × 0.25","$731,250"],["Common-benefit assessment","$731,250 × 0.08","$58,500"],["Net fee","$731,250 − $58,500","$672,750"],["Workup costs","30 × $2,500","$75,000"],["Undiscounted profit","$672,750 − $75,000 − $150,000","$447,750"],["Discount factor","1.12 ^ (54 ÷ 12) = 1.12 ^ 4.5","1.6653"],["Net fee in today's dollars","$672,750 ÷ 1.6653","about $403,990"],["Profit in today's dollars","$403,990 − $75,000 − $150,000","about $178,990"],["Break-even CPSR, undiscounted","($672,750 ÷ 30) − $2,500","$19,925"],["Break-even CPSR, discounted","($403,990 ÷ 30) − $2,500","about $10,970"]]},{"type":"paragraph","text":"In this hypothetical, the program pays at a $5,000 cost per signed retainer, and would still pay at roughly $10,970 once the wait is priced in. Above that, it loses money in today's dollars even if the tort settles exactly as assumed."},{"type":"heading","level":3,"text":"Sensitivity: attrition and months to payment"},{"type":"paragraph","text":"The two inputs firms most often get wrong are attrition and time. The table holds every other hypothetical input from the worked example constant and shows the discounted break-even cost per signed retainer."},{"type":"table","header":["Hypothetical attrition","30 months to payment","54 months","120 months"],"rows":[["15%","$19,590","$15,110","$6,942"],["35%","$14,392","$10,966","$4,720"],["60%","$7,895","$5,787","$1,943"]]},{"type":"paragraph","text":"How each cell is built: $34,500 (that is $150,000 × 0.25 × 0.92) × (1 − attrition), divided by 1.12 raised to (months ÷ 12), minus $2,500. The discount factors are 1.3275 at 30 months, 1.6653 at 54 months and 3.1058 at 120 months."},{"type":"paragraph","text":"Read across the bottom row. With 60% attrition and a ten-year wait, the most you can pay per signed retainer is under $2,000, close to the bottom of our published range. A tort that drags like talc, with high attrition, can make almost any acquisition cost unprofitable."},{"type":"heading","level":3,"text":"Sensitivity: award size and fee rate"},{"type":"paragraph","text":"Award size moves the answer even more. This table keeps 35% attrition, an 8% assessment, $2,500 workup and a 54-month wait, all hypothetical, and varies the gross award and the fee rate."},{"type":"table","header":["Hypothetical gross award","Fee rate 20%","Fee rate 25%"],"rows":[["$25,000","−$704","−$256"],["$150,000","$8,273","$10,966"],["$300,000","$19,046","$24,433"]]},{"type":"paragraph","text":"At a $25,000 award, the break-even cost is below zero at both fee rates: the program loses money at any acquisition price. Roundup's 2026 class deal starts at $10,000 per claimant, so a tort whose typical claimant sits near the bottom of a settlement grid can be unprofitable to advertise no matter how efficient the agency is."},{"type":"heading","level":3,"text":"How to use the model"},{"type":"paragraph","text":"Run three versions for every tort you consider: a careful case, a middle case and a bad case. Use your own fee agreements, your own records costs and your own cost of capital. If the bad case leaves you unable to meet payroll, the tort is too big a bet for your firm at that budget, whatever the middle case says."},{"type":"heading","level":2,"text":"Five tests your firm must pass first"},{"type":"paragraph","text":"Before hiring any agency, a firm should pass five tests: capital reserves, intake capacity, risk tolerance, time horizon and docket choice. Failing any one of them usually turns a good agency into a losing investment, so each test below includes a rule-of-thumb threshold and what to do if you fall short."},{"type":"image","src":"/images/blog-content/is-mass-tort-marketing-agency-worth-it/03-readiness-scorecard.jpg","alt":"Five-card scorecard for capital reserves, intake capacity, risk tolerance, time horizon and docket choice","caption":"A firm that fails any one of these tests usually loses money on an agency, however good the agency is."},{"type":"paragraph","text":"The thresholds are my opinion, based on the timelines and attrition examples above. They are not industry data. Adjust them to your firm, but write your own version down before you sign anything."},{"type":"table","header":["Test","Rule-of-thumb pass","If you fail"],"rows":[["Capital reserves","Planned spend plus workup costs covered for 36+ months","Smaller budget, one tort, or refer out"],["Intake capacity","Calls answered 24/7 and records requested within days","Fix intake before buying media"],["Risk tolerance","Firm survives one tort going to zero","Spread across torts or buy retainers"],["Time horizon","Partners accept fees in year 3 to 8","Stay in single-event PI"],["Docket choice","Written thesis on stage, science and criteria","Wait for MDL creation and early rulings"]]},{"type":"heading","level":3,"text":"Test 1: capital reserves"},{"type":"paragraph","text":"The test: can your firm fund the whole planned spend, plus workup costs, plus overhead, for at least three years without needing a fee from that tort? The 36-month figure is a rule of thumb. Philips CPAP moved from MDL to settlement in about 2 years 7 months; AFFF took nearly 8 years."},{"type":"paragraph","text":"If you fail, cut the program to a size you can carry, run one tort instead of three, or refer cases out to a firm with deeper reserves. Borrowing to fund acquisition is possible, but put its cost into the break-even model before you sign."},{"type":"heading","level":3,"text":"Test 2: intake capacity"},{"type":"paragraph","text":"The test: can someone qualified answer a claimant's call at 9 p.m. on a Saturday, in the claimant's language, and does your team request medical and product records within days of signing? A missed call is a lead you paid for and gave to a competitor. A slow records request is a fact-sheet deadline you may miss."},{"type":"paragraph","text":"If you fail, fix intake before you spend on media. That may mean an outsourced overnight service, a bilingual hire, or an agency that screens before delivery. Our [mass tort intake](/mass-tort-intake) page and [mass tort intake guide](/mass-tort-intake) cover what good intake looks like."},{"type":"heading","level":3,"text":"Test 3: risk tolerance"},{"type":"paragraph","text":"The test: if one tort went to zero, as federal Zantac claims did after the 2022 expert ruling, would your firm survive? Would the partners still agree the program was a reasonable bet? Mass torts are a portfolio business. A single-tort program is a concentrated bet on one set of experts, one judge and one defendant's settlement appetite."},{"type":"paragraph","text":"If you fail, spread a smaller budget across two or three torts at different stages, or buy signed retainers from a co-counsel partner so that some of the risk sits elsewhere."},{"type":"heading","level":3,"text":"Test 4: time horizon"},{"type":"paragraph","text":"The test: do the partners who sign off on the budget accept that fees may arrive in year three, five or eight? This sounds the same as the capital test, but it is about patience rather than money. Programs often die in month nine because a partner sees a large expense line and no revenue, even though nothing about the tort has changed."},{"type":"paragraph","text":"If you fail, either get written agreement on the horizon before launch, or stay with single-event PI, where the feedback loop is months rather than years."},{"type":"heading","level":3,"text":"Test 5: docket choice"},{"type":"paragraph","text":"The test: can you explain, in writing, why this tort and why now? A good thesis covers the litigation stage (MDL created or not, bellwethers scheduled or not), the state of the science, the qualification criteria, and the likely value range. The JPML [granted 21 of 32 MDL petitions](https://www.dechert.com/knowledge/re-torts/2026/1/product-liability-litigation-and-the-2025-judicial-panel-on-mult.html) it considered in 2025, and it has [twice denied centralization](https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3168-Order_Denying_Transfer-12-25.pdf) of video game addiction suits. Advertising for a tort before the panel acts is a bet on that decision."},{"type":"paragraph","text":"If you fail, wait. Joining after MDL creation and early science costs more per retainer, but late joiners in the 3M earplug MDL paid a higher common-benefit percentage too, so being early is not free either. Pick the trade-off on purpose."},{"type":"heading","level":3,"text":"Scoring yourself"},{"type":"paragraph","text":"Score each test pass, borderline or fail. In my view, a firm with any fail should not hire an agency yet, and a firm with two borderlines should start with a small, single-tort pilot. A firm that passes all five is ready to evaluate vendors, which is where the next section starts."},{"type":"heading","level":2,"text":"Agency, lead vendor, co-counsel or in-house: which is worth it"},{"type":"paragraph","text":"There are four main ways to acquire mass tort cases: hire a marketing agency, buy leads from a vendor, buy into signed retainers through a co-counsel arrangement, or build an in-house team. Each trades control and data ownership against capital and effort, and the right choice depends on which of the five tests your firm passes."},{"type":"image","src":"/images/blog-content/is-mass-tort-marketing-agency-worth-it/04-buying-models.jpg","alt":"Matrix comparing marketing agency, lead vendor, co-counsel retainer buy and in-house team by control and upfront capital","caption":"The four ways to acquire mass tort cases trade control against capital and effort. None is best for every firm."},{"type":"paragraph","text":"The table below is a qualitative comparison. \"High\" and \"low\" are relative to the other routes, not measurements."},{"type":"table","header":["Factor","Marketing agency","Lead vendor","Co-counsel retainer buy","In-house team"],"rows":[["Upfront capital","Medium to high","Low to medium","Medium","High"],["Control over creative and intake","Medium to high","Low","Low","Full"],["Claimant data ownership","Depends on contract","Often shared or limited","With lead counsel","Full"],["Share of fee kept","Full fee","Full fee","Reduced by split","Full fee"],["Speed to first cases","Weeks","Days","Days","Months"],["Main risk","Paying for leads that never sign","Shared or recycled leads","Split erodes margin","Fixed cost with no cases"]]},{"type":"heading","level":3,"text":"Marketing agency"},{"type":"paragraph","text":"An agency gives you your own campaigns, your own claimants and, with the right contract, your own data. You pay for media and management whether or not cases sign, so the agency route rewards firms with strong intake and punishes firms without it. This route makes most sense for firms that pass all five tests and want to keep the full fee."},{"type":"heading","level":3,"text":"Lead vendor"},{"type":"paragraph","text":"A lead vendor sells leads or transfers at a per-unit price. It is the fastest and cheapest way to start, and the easiest to stop. The risks are lead quality, exclusivity and consent records. If the same claimant is sold to three firms, you are paying to compete for a person who may already have signed elsewhere. Insist on [exclusive leads](/exclusive-mass-tort-leads) and a written return window. Our comparison of [agencies versus lead vendors](/mass-tort-marketing-vs-legal-lead-vendors) goes into the differences."},{"type":"heading","level":3,"text":"Co-counsel retainer buy"},{"type":"paragraph","text":"Some firms skip acquisition and buy into signed retainers through a co-counsel or referral arrangement, sharing the fee under Rule 1.5(e). You give up part of the fee, but you also share the litigation work and risk with a firm that may already be in leadership. Our page on [alternatives to Broughton Partners](/broughton-partners-alternative) discusses this co-counsel model, and the page on [alternatives to Adwire Media](/adwire-media-alternative) covers vendors that price at a fixed amount per claimant."},{"type":"heading","level":3,"text":"In-house team"},{"type":"paragraph","text":"Building in-house means hiring media buyers, creative staff and intake, and paying for tools and ad accounts directly. You get full control and full data, and you carry fixed salaries whether or not a tort is active. In my view, in-house only pays once a firm runs enough volume across enough torts to keep a team busy year-round, and most firms reach that point after working with outside partners first."},{"type":"heading","level":3,"text":"Mixing routes"},{"type":"paragraph","text":"Many firms combine them: an agency for the one or two torts where they want to own the relationship, a lead vendor for overflow, and co-counsel for torts they will not litigate. If you are comparing vendors across routes, our list of [top mass tort marketing firms](/top-mass-tort-marketing-firms) is one place to start. Whatever mix you choose, make each route report the same metric, cost per signed retainer, so you can compare them on equal terms."},{"type":"heading","level":3,"text":"Matching the route to your test results"},{"type":"paragraph","text":"The five tests point to a route more often than not. The mapping below is my opinion, not data, and a firm can move between routes as its capital and intake change."},{"type":"table","header":["If your firm...","Route that usually fits"],"rows":[["Passes all five tests","Agency, possibly growing into in-house"],["Fails capital, passes intake","Lead vendor at a small budget, or co-counsel"],["Fails intake","Co-counsel until intake is fixed"],["Fails risk tolerance","Several small lead tests, or co-counsel"],["Fails time horizon","Refer out and stay in single-event PI"],["Fails docket choice","Wait, or co-counsel with a firm in leadership"]]},{"type":"paragraph","text":"Two cautions apply across all four routes. First, compare total cost to a paid fee, not the headline price. A lead vendor's cheaper unit price can produce a higher cost per signed retainer if the leads are shared, and a co-counsel buy that looks cheap up front can cost more once the fee split is counted. Second, make sure every route leaves you with consent records for each claimant, because the TCPA and bar exposure discussed next follows the firm whichever route found the client."},{"type":"heading","level":2,"text":"Compliance costs that change the answer"},{"type":"paragraph","text":"Compliance changes the answer because a single bad calling or advertising practice can cost more than a campaign earns. In 2026 the main exposures are TCPA damages for unconsented calls and texts, bar rules on advertising and solicitation, and state-specific rules, and the firm usually carries the liability even when a vendor made the call. This section is general information, not legal advice; rules vary by state."},{"type":"heading","level":3,"text":"TCPA status in 2026"},{"type":"paragraph","text":"The FCC's one-to-one consent rule is not in effect. The Eleventh Circuit in *Insurance Marketing Coalition Ltd. v. FCC* [vacated the rule](https://www.mofo.com/resources/insights/250130-eleventh-circuit-vacates-fcc-s-tcpa-one-to-one-consent-rule) on January 24, 2025, and the FCC then [removed the vacated language](https://www.goodwinlaw.com/en/insights/blogs/2025/09/the-fcc-issues-final-rule-formally-eliminating-the-one-to-one-consent-requirement) and restored the earlier consent text. If a vendor describes the one-to-one rule as a current requirement, treat that as a sign its compliance information is out of date."},{"type":"paragraph","text":"The underlying statute did not change. The TCPA still lets a person sue for the greater of actual loss or $500 per violation, and a court may treble that for willful or knowing violations. In June 2025, the Supreme Court held in *McLaughlin Chiropractic Associates v. McKesson Corp.* that district courts are [not bound by FCC interpretations](https://www.gibsondunn.com/supreme-court-holds-that-district-courts-are-not-bound-by-agency-interpretations-in-enforcement-proceedings/) of the TCPA in enforcement proceedings, so courts may read consent requirements differently from the agency."},{"type":"heading","level":3,"text":"What TCPA claims look like for law firms"},{"type":"paragraph","text":"These risks are not theoretical. Wilshire Law Firm agreed to pay [up to $5.975 million](https://www.classaction.org/news/up-to-5.975m-wilshire-law-firm-settlement-ends-class-action-over-allegedly-unlawful-prerecorded-calls) to settle a TCPA class action over prerecorded calls to prospective clients, with preliminary approval on February 18, 2026. In March 2025, a legal lead generator was [sued in a TCPA class action](https://natlawreview.com/article/plot-twist-legal-lead-generator-sued-tcpa-class-action) over voicemails about talc and rideshare assault claims. At $500 to $1,500 per call, a few thousand unconsented calls can exceed the fees from an entire campaign."},{"type":"heading","level":3,"text":"Bar rules on advertising and solicitation"},{"type":"table","header":["Rule","What it covers","Why it costs money"],"rows":[["ABA Model Rule 7.1","False or misleading communications","Pulled ads, discipline, rework"],["ABA Model Rule 7.2(b)","Paying for recommendations","Vendor fee structures must fit exceptions"],["ABA Model Rule 7.3(b)","Live person-to-person solicitation","Outbound call scripts may be barred"],["ABA Model Rule 5.3","Supervising nonlawyers, including vendors","Firm answers for vendor conduct"],["ABA Model Rule 5.4","Fee sharing with nonlawyers","No percentage-of-fee marketing deals"]]},{"type":"paragraph","text":"[Rule 7.2(b)](https://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/rule_7_2_advertising/) bars giving anything of value for recommending a lawyer, with exceptions that include the reasonable costs of permitted advertising; comment guidance allows paying vendors for marketing or client-development services. State adoptions differ, including in Illinois, New Hampshire and Ohio."},{"type":"paragraph","text":"[Rule 7.3(b)](https://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/rule_7_3_solicitation_of_clients/) bars live person-to-person solicitation when a significant motive is pecuniary gain, and its comments treat live phone calls as covered while texts and email are not. An agency that cold-calls possible claimants on your behalf can put your own license at risk."},{"type":"paragraph","text":"[Rule 5.3](https://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/rule_5_3_responsibilities_regarding_nonlawyer_assistant/) requires lawyers to make reasonable efforts to ensure that nonlawyers they retain, including outside vendors, act compatibly with the lawyer's obligations. In practice, that means you need to know how your agency generates and contacts claimants."},{"type":"heading","level":3,"text":"State examples"},{"type":"list","ordered":false,"items":["**Texas:** under the civil barratry statute, a client may void a contract procured through barratry and recover remedies including [a $10,000 penalty](https://texas.public.law/statutes/tex._gov't_code_section_82.0651) and attorney's fees.","**Florida:** Bar Rule 4-7.19 requires filing each advertisement at least 20 days before first use, with a [$150 fee per timely filed ad](https://www.floridabar.org/the-florida-bar-news/proposed-amendments-to-bar-rules-4-7-19-4-7-20-4-8-6-and-4-7-19/) ($250 if late); a proposed amendment would let the Bar set the fee, so confirm the current amount.","**Drug-injury ads:** Tennessee (2019, all media) and Texas (2019, TV) [require warnings](https://www.shb.com/intelligence/publications/attorney-articles/q3/behrens-deceptive-lawyer-advertising-iadc) not to stop medication without consulting a doctor, and the Fourth Circuit upheld West Virginia's similar law in 2022."]},{"type":"heading","level":3,"text":"Who carries the liability"},{"type":"paragraph","text":"When a vendor makes a call or runs an ad for your firm, the claimant, the court and the bar will usually look at your firm. Contracts can shift some cost through indemnity, but an indemnity from an agency without the assets to pay it is worth little. Ask for consent records on every lead, proof of insurance, and the right to audit scripts and call recordings. Our [mass tort marketing compliance](/mass-tort-marketing-compliance) page covers these checks in more detail."},{"type":"heading","level":2,"text":"What is different about 2026"},{"type":"paragraph","text":"In 2026 the mass tort market is bigger, more crowded and more tightly regulated than a few years ago: new dockets are growing fast, legal ad spending keeps rising, funders face more state rules, and investor money is moving into law firm back offices. None of this makes an agency more or less worth it on its own, but each shifts the inputs."},{"type":"heading","level":3,"text":"Docket momentum"},{"type":"paragraph","text":"Several newer dockets grew sharply between the JPML's [February 2026 report](https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-February-2-2026.pdf) and its November 2026 report. The percentages are our calculation from JPML counts."},{"type":"table","header":["MDL","Feb 2, 2026","Nov 2, 2026","Change"],"rows":[["Depo-Provera (MDL 3140)","2,098","6,413","about 3.1x"],["Social media addiction (MDL 3047)","2,325","4,309","+85%"],["Bard implanted port (MDL 3081)","2,674","4,345","+62%"],["GLP-1 RAs (MDL 3094)","3,191","4,082","+28%"],["Hair relaxer (MDL 3060)","11,195","12,743","+14%"]]},{"type":"paragraph","text":"Fast growth means more firms competing for the same claimants, which tends to push acquisition costs up. It also means some litigation is moving: in March 2026, a Los Angeles jury found Meta and YouTube liable in the [first social media addiction bellwether](https://www.aljazeera.com/economy/2026/3/25/us-jury-finds-meta-alphabet-liable-in-landmark-social-media-addiction-case) in the state JCCP, awarding $3 million in compensatory and $3 million in punitive damages, and Meta said it would appeal."},{"type":"paragraph","text":"MDLs remain a large share of federal civil litigation. Reported estimates in 2024 put [65% to 71% of the federal civil caseload](https://law.com/2024/06/25/mdls-make-up-more-than-half-of-u-s-cases-whether-its-65-or-71) in MDLs, depending on the method; we found no official 2025 or 2026 figure."},{"type":"heading","level":3,"text":"More money chasing claimants"},{"type":"paragraph","text":"Legal advertising keeps growing. The American Tort Reform Association, an advocacy group that opposes much plaintiff litigation, [estimated](https://www.atra.org/white_paper/legal-services-ads-2020-2024) more than $2.5 billion on 26.9 million legal services ads in 2024, up about 39% from 2020, and [about $4 billion in 2025](https://atra.org/white-paper-and-repo/or-local-legal-services-ads-21-25/). AdImpact, an ad-tracking firm, [projects legal ad spend above $3 billion](https://adimpact.com/reports/legal-advertising-trends-report) a year. These figures cover all legal services ads, not mass torts alone, and the insurance group Triple-I has used them to [argue for limits](https://www.insurancejournal.com/magazines/mag-features/2025/06/16/827442.htm) on advertising and funding."},{"type":"heading","level":3,"text":"Capital and ownership shifts"},{"type":"paragraph","text":"Investor interest in Arizona's nonlawyer-owned law firm program has [cooled](https://news.bgov.com/litigation-finance/investors-chase-law-firm-back-offices-as-arizona-interest-cools), with most investors now choosing management services organizations instead. One Arizona firm [separated its back office for a $125 million investment](https://news.bloomberglaw.com/private-equity/arizona-law-firm-severs-back-office-for-125-million-investment). Arizona also [updated its rules](https://news.bgov.com/us-law-week/private-equity-flows-into-arizona-to-run-national-tort-firms) to curb firms using the program to generate leads for lawyers in other states. Meanwhile, California has barred fee sharing with these entities, and Colorado and Illinois approved similar measures in 2026. For an agency buyer, this means more well-funded competitors bidding for the same audiences."},{"type":"heading","level":3,"text":"How firms and claimants search"},{"type":"paragraph","text":"Search behavior is also shifting. Claimants and lawyers increasingly ask AI assistants which firm or vendor to use, and those answers draw on whatever the web says about a tort or an agency. That rewards vendors with clear, checkable public information, and it is a reason to ask any agency where its claims about results come from."},{"type":"heading","level":3,"text":"What 2026 means for your plan"},{"type":"paragraph","text":"Put together, these signals argue for more caution about timing, not less. The JPML still centralizes most product cases it is asked to: of five product liability petitions in 2025, it granted four. But a centralized docket is only the start, and 2026 brought reminders that rulings can reshape a tort years in, from the Supreme Court's Roundup preemption decision to the reversal of the $60 million NEC verdict."},{"type":"paragraph","text":"In my view, a firm entering a growing docket in 2026 should budget for higher acquisition costs than it saw a year earlier, check the tort's latest rulings before every budget increase, and keep its break-even model current as settlements and verdicts change the expected award."},{"type":"heading","level":2,"text":"How to run a test that tells you the truth"},{"type":"paragraph","text":"A useful test runs one tort for about 90 days with written criteria, a budget large enough to produce a readable number of signed cases, weekly reporting on qualified and signed retainers, and stop and scale rules set before launch. A 90-day test cannot show a paid fee, so it judges the steps you can measure and builds the data you need for the break-even model."},{"type":"image","src":"/images/blog-content/is-mass-tort-marketing-agency-worth-it/05-metric-ladder.jpg","alt":"Staircase of metrics rising from cost per lead to net fee per dollar spent","caption":"Cost per lead is the easiest number to report and the least useful. Judge a test on the highest step you can measure."},{"type":"paragraph","text":"The goal of a pilot is a decision, not a profit. At the end, you should know your real cost per signed retainer for that tort, how many signed cases passed records review, and whether your intake kept up."},{"type":"heading","level":3,"text":"Step 1: pick one tort"},{"type":"paragraph","text":"Choose a tort that passes your docket-choice test and where your firm, or a co-counsel partner, can actually litigate or place the cases. Running three torts in a pilot splits a small budget three ways and produces three unreadable results."},{"type":"heading","level":3,"text":"Step 2: write the criteria down"},{"type":"paragraph","text":"Before launch, put the qualification criteria in writing: product or exposure, diagnosis, dates, age limits, and statute of limitations rules for your target states. Share them with the agency and require that screening follows them. Our article on [mass tort qualification criteria](/blogs/mass-tort-qualification-criteria) shows how to structure this. Written criteria are also what makes a replacement clause enforceable."},{"type":"heading","level":3,"text":"Step 3: set a budget that can produce an answer"},{"type":"paragraph","text":"Work backward from the number of signed cases you need to judge the tort. If you want at least 20 signed retainers to read the results, and the tort's published cost per signed retainer estimate is $5,000, you need about $100,000 of spend. A budget that produces five signed cases tells you very little, because a few good or bad weeks can swing the average."},{"type":"heading","level":3,"text":"Step 4: track weekly KPIs"},{"type":"table","header":["Metric","Target type","Red flag"],"rows":[["Speed to first contact","Minutes, set in writing","Calls returned next day"],["Lead-to-qualified rate","Trend within the pilot","Falling for three weeks"],["Cost per qualified lead","Against your model","Rising with flat spend"],["Cost per signed retainer","Below break-even","Above discounted break-even"],["Records requested within 7 days","Share of signed cases","Backlog growing"],["Signed cases passing records review","Share of signed cases","Many fail product or diagnosis proof"],["Replacement requests","Count and reasons","Same failure repeating"]]},{"type":"paragraph","text":"Our pages on [mass tort lead conversion rates](/mass-tort-lead-conversion-rates) and [ad spend versus signed retainers](/blogs/ad-spend-vs-signed-retainers) explain how to read these numbers together."},{"type":"heading","level":3,"text":"Step 5: set stop and scale rules in advance"},{"type":"paragraph","text":"Write the rules before the first dollar is spent, while nobody is attached to the result. A simple version, offered as a rule of thumb: stop if cost per signed retainer stays above your discounted break-even for six straight weeks after the first month; hold if it sits between your middle and bad-case break-even; scale in steps only if it stays below your middle case and records review confirms the cases are real. Add spend gradually, because acquisition costs often rise as you buy more of a fixed audience."},{"type":"heading","level":3,"text":"Step 6: insist on the right contract terms"},{"type":"list","ordered":false,"items":["**Ad account ownership:** accounts in your firm's name, or full access and a transfer clause.","**Exclusivity:** each claimant delivered to your firm only, in writing.","**Consent records:** a record of consent for every lead, kept by you.","**Replacement terms:** a defined window and process for leads that miss agreed criteria.","**Reporting:** weekly, by tort, through to signed retainers.","**Exit terms:** month-to-month or a short notice period, with data handed over on exit.","**Compliance:** script approval rights, no live outbound solicitation, proof of insurance."]},{"type":"paragraph","text":"For more questions to put to a vendor before signing, see [questions to ask a mass tort marketing agency](/how-to-choose-a-mass-tort-marketing-agency)."},{"type":"heading","level":3,"text":"Step 7: read the results at day 90"},{"type":"paragraph","text":"At the end of the pilot, put three numbers next to each other: your actual cost per signed retainer, the share of signed cases that passed records review, and your discounted break-even from the model. Then adjust the model's attrition input using what records review showed. If 30% of signed cases already failed product or diagnosis proof, your attrition before compensation will be higher than that, not lower."},{"type":"paragraph","text":"The decision is usually one of three. Scale, if cost per signed retainer sits comfortably below your updated break-even and intake kept pace. Fix and retest, if the cost was close but intake or criteria clearly caused the losses. Stop, if the cost was well above break-even with good intake, because the problem then lies in the tort or the market, and more money will not change it. Whatever you decide, keep the claimants you signed moving: the spend is already sunk, and those cases are now the only way to recover it."},{"type":"heading","level":2,"text":"Is Mass Tort Marketing Agency, the company, worth it?"},{"type":"paragraph","text":"This section is about us, so read it as a vendor describing itself. Mass Tort Marketing Agency is worth considering for firms that pass the five tests, want exclusive claimants and their own ad accounts, and can commit at least $25,000 a month per tort for long enough to read the results. For many firms that is not the right fit, and the list below says so plainly."},{"type":"paragraph","text":"Mass Tort Marketing Agency LLC was founded in 2019 and is based in Long Beach. We run paid acquisition and intake for plaintiff firms; we do not litigate, take a share of fees or guarantee case outcomes."},{"type":"heading","level":3,"text":"Our model, as of November 2026"},{"type":"table","header":["Term","What we offer"],"rows":[["Mass tort program","From $25,000 per month per tort, ad spend included"],["MVA program","From $10,000 per month, ad spend included"],["Media billing","At cost, with platform invoices disclosed"],["Ad accounts","Your firm keeps ownership and visibility"],["Leads","Exclusive; delivered to one firm only"],["Intake","24/7 bilingual intake"],["Replacement","Leads missing agreed criteria replaced; request within 7 days with a documented reason"],["Contract","Month-to-month, 30 days notice to cancel, no setup fees"],["Changing torts","Add or pause at a billing cycle start with 15 days notice"]]},{"type":"paragraph","text":"These terms are published on our [pricing page](/pricing) and described in more detail on our [mass tort marketing agency](/mass-tort-marketing-agency) page. Our cost per signed retainer estimates are the published 2026 figures used earlier in this guide; they are our estimates, not independent benchmarks, and your results will depend on your tort, market and intake."},{"type":"heading","level":3,"text":"Applying the five tests to ourselves"},{"type":"paragraph","text":"On capital, our pricing floor is a real cost: a six-month mass tort test at our minimum is $150,000 before any fee arrives. On intake, we provide 24/7 bilingual screening, but your firm still has to collect records and meet fact-sheet deadlines. On risk, month-to-month terms let you stop a tort that is not working, though they cannot recover what you already spent. On time horizon, nothing in our model shortens the litigation. On docket choice, we will tell you which torts we run, but the decision and the litigation risk are yours."},{"type":"heading","level":3,"text":"Where I think we fit"},{"type":"paragraph","text":"In my opinion, we fit best with two kinds of firms. The first is an established mass tort firm that already handles records and fact sheets and wants more exclusive claimants on a tort it is litigating, without hiring a media team. The second is a well-capitalized PI firm adding its first one or two torts, which can also use our MVA program to keep single-event cases coming in while the mass tort docket matures. In both cases, the firm should run the pilot described above with us exactly as it would with any other vendor, using its own break-even model to judge the result."},{"type":"heading","level":3,"text":"Do not hire us if..."},{"type":"list","ordered":false,"items":["You cannot commit $25,000 a month per tort for at least two quarters, plus years of carrying costs before fees arrive.","You want a vendor paid from a share of your case fees, or one that guarantees a number of signed or accepted cases.","Your firm has no one to request records and manage fact sheets after a claimant signs.","You want shared or resold leads at a lower price; we only sell exclusive leads.","You want to buy signed retainers through a co-counsel arrangement rather than build your own docket.","You need a single tort to pay back within a year.","You want outbound cold calling or texting to people who have not asked to be contacted."]},{"type":"paragraph","text":"If one of those describes your firm, another route or another vendor is likely a better fit. Our page on [Mass Tort Marketing Agency alternatives](/mass-tort-marketing-agency-alternatives) lists options, including models we do not offer."},{"type":"heading","level":2,"text":"Sources and methodology"},{"type":"paragraph","text":"Every fact in this guide was checked on November 11, 2026, against the sources linked where it first appears. We preferred primary sources: JPML docket reports, court orders and filings, statutes, DOJ and Navy releases, company press releases and SEC filings. Where only press coverage was available, we linked a named publication and said so. Advocacy groups such as ATRA and Triple-I are identified as advocacy groups."},{"type":"paragraph","text":"The ABA's website blocked automated access, so Model Rule wording was checked against state adoptions and secondary sources; confirm exact text on americanbar.org before relying on it. Some items were still moving on the check date, including final approval of the 2026 Roundup class settlement."},{"type":"paragraph","text":"All break-even inputs, sensitivity tables and the worked example are hypothetical and labelled as such. Calculations marked as ours are simple arithmetic on cited figures. Cost per signed retainer figures are Mass Tort Marketing Agency's own published estimates; we found no independent source that publishes them. Widely repeated figures with no traceable source were left out."},{"type":"paragraph","text":"Mass Tort Marketing Agency sells the services discussed here. This guide was written by the MTMA Editorial Team under our [editorial standards](/editorial-standards). It is general information, not legal or financial advice."}],"faqs":[{"question":"Is a mass tort marketing agency worth it in 2026?","answer":"It can be, for a firm that can fund spend for years, answer and work up claimants quickly, survive a tort that fails, pick dockets at the right stage, and measure cost per signed and accepted case. Large MDLs in this guide took from about 2 years 7 months to almost 8 years to reach settlement, and payments often ran longer. Firms that need fast payback or lack intake depth usually do better referring cases out, buying leads on strict terms or staying in single-event PI."},{"question":"How much does a mass tort marketing agency cost?","answer":"Pricing varies by model. Mass Tort Marketing Agency's published 2026 estimates put cost per lead at $50 to $500 and cost per signed retainer at $1,800 to $15,000, depending on the tort; these are our estimates, since no independent source publishes them. Some agencies charge a monthly fee plus media, others price per lead or per retainer. As of November 2026, our own mass tort programs start at $25,000 a month per tort with ad spend included. Our [mass tort lead generation cost](/mass-tort-lead-generation-cost) page compares pricing models."},{"question":"How long until a mass tort case pays?","answer":"Usually years. In the dockets reviewed here, MDL creation to settlement took about 2 years 7 months for Philips CPAP, about 4 years 5 months for 3M earplugs, about 6 years 2 months for Bard hernia mesh and almost 8 years for AFFF personal injury claims. Payment then follows its own schedule: 3M's earplug deal pays out between 2023 and 2029, and the AFFF commitment runs through 2034. J&J talc has no global resolution after about ten years."},{"question":"What is a good cost per signed retainer?","answer":"A good cost per signed retainer is one below your own break-even, which depends on award size, attrition, fee rate, assessments and how long you wait. Our published 2026 estimates range from $1,800 to $15,000 by tort, such as $2,500 to $7,500 for hair relaxer and $5,000 to $15,000 for NEC. In this guide's hypothetical model, a $150,000 award, 35% attrition, 25% fee and 54-month wait support up to about $10,970 per signed case in today's dollars."},{"question":"What percentage of mass tort leads sign?","answer":"There is no reliable independent figure, and it varies widely by tort, channel and intake quality. Our cost per signed retainer post uses an illustration in which 100 leads produce 12 qualified leads and 6 signed retainers, but that is an example, not a benchmark. The more useful question is what share of your signed cases survive records review and become compensable. Track lead-to-qualified, qualified-to-signed and signed-to-accepted rates separately during a pilot, and build your model from your own numbers."},{"question":"Is mass tort advertising profitable for small firms?","answer":"It can be, but small firms face the hardest version of the capital test. A six-month test at $25,000 a month is $150,000 before any fee arrives, and fees may take four years or more. A small firm that cannot carry that, or cannot absorb a tort going to zero, is usually better off referring cases to a larger firm under a written fee division or buying a limited number of exclusive leads with clear return terms. Profit depends on surviving the wait."},{"question":"Should I buy leads or hire an agency?","answer":"Buy leads if you want speed, low commitment and a small test, and you have strong intake to convert them. Hire an agency if you want control over creative, screening and data, and you can commit a larger budget for longer. Either way, require exclusivity, consent records and a written return window, and compare both routes on cost per signed retainer. The comparison of agencies and lead vendors linked in the routes section above covers the trade-offs in more detail."},{"question":"What is a common benefit fee?","answer":"A common benefit fee is a court-ordered assessment, taken from recoveries in an MDL, that pays lawyers for shared work such as discovery, experts and bellwether trials. Philips CPAP set 10%, with 8% for fees and 2% for expenses. In Roundup, the judge ordered an 8% holdback from attorney fees. The 3M earplug order charged a higher percentage to firms that signed the participation agreement later. The assessment comes off before your fee reaches your firm, so include it in any break-even model."},{"question":"Can I finance mass tort advertising?","answer":"Yes, some firms use litigation funding or credit lines, but financing adds a cost that comes out of your fees, and terms are negotiated privately, so there is no published benchmark rate. Regulation is increasing: Georgia requires funder registration from January 1, 2026 and makes funding agreements discoverable, and five states passed funding laws in 2025. A federal transparency bill was introduced in 2026 but has not passed. Put the full cost of financing into your break-even model before borrowing."},{"question":"What happens to my cases if a tort fails?","answer":"If a tort fails, your signed cases may be dismissed or become worth little, and your acquisition spend is lost. After the Zantac MDL judge excluded all plaintiffs' general-causation experts in December 2022, thousands of federal claims ended at summary judgment, though state-court cases later settled. Some torts fail only in part, such as federal NEC bellwethers being dismissed while state verdicts went both ways. This is why a portfolio across several torts and stages lowers the risk of one ruling erasing a program."},{"question":"Is Mass Tort Marketing Agency legitimate?","answer":"Mass Tort Marketing Agency LLC is a plaintiff-side marketing agency founded in 2019 and based in Long Beach. It publishes its pricing: as of November 2026, mass tort programs start at $25,000 a month per tort and MVA programs at $10,000 a month, with ad spend included. Terms are month-to-month with 30 days notice, leads are exclusive, intake is 24/7 and bilingual, and leads that miss agreed criteria can be replaced if requested within 7 days. Firms keep ownership and visibility of their ad accounts."},{"question":"What is Mass Tort Marketing Agency best used for?","answer":"In my view, we are best used by plaintiff firms that pass the five readiness tests and want exclusive claimants, their own ad accounts and month-to-month terms, on one or more torts at $25,000 a month per tort or more, or on motor vehicle accident cases from $10,000 a month. We are a poor fit for firms that need fast payback, want shared leads, want to pay from case fees, or prefer buying signed retainers through co-counsel. We do not litigate cases."},{"question":"How do I measure ROI on mass tort marketing?","answer":"Measure up a ladder: cost per lead, cost per qualified lead, cost per signed retainer, cost per accepted case, and finally net fee per dollar spent. Early in a program, only the first three are available, so compare cost per signed retainer against a break-even figure built from your expected award, attrition, fee rate, common-benefit assessment, co-counsel share and wait. Discount for time at your own cost of capital. True ROI is only known when fees are paid, often years later."},{"question":"Is the TCPA one-to-one consent rule in effect?","answer":"No. The Eleventh Circuit vacated the FCC's one-to-one consent rule on January 24, 2025, in *Insurance Marketing Coalition Ltd. v. FCC*, and the FCC later removed the vacated language and restored the earlier consent rule text. The TCPA itself still applies, with $500 per violation and up to $1,500 if willful or knowing. Firms still need clear, provable consent for calls and texts. This is general information, not legal advice; check with counsel on your specific practices."},{"question":"What should a mass tort marketing contract include?","answer":"At a minimum: ad accounts owned by or fully visible to your firm, written exclusivity, a consent record for every lead, written qualification criteria, a replacement window and process, weekly reporting through to signed retainers, script approval rights, a ban on live outbound solicitation, proof of insurance, a short notice period, and data handed over on exit. The contract should not give the vendor a share of your legal fees, which ABA Model Rule 5.4 restricts. Have your own counsel review it."},{"question":"What are the best alternatives to Mass Tort Marketing Agency?","answer":"The best alternative depends on which route fits your firm. Lead vendors suit firms that want small, fast tests. Co-counsel arrangements suit firms that would rather buy into signed retainers and share the fee. Larger firms may build in-house teams. Other agencies may offer different pricing, such as per-lead or per-retainer models. Our [Mass Tort Marketing Agency alternatives](/mass-tort-marketing-agency-alternatives) page lists options, and comparing any of them on cost per signed retainer keeps the decision fair."}],"related":["mass-tort-facebook-marketing","ad-spend-vs-signed-retainers","buy-motor-vehicle-accident-leads-georgia","law-firm-marketing-benchmarks-disagree"]}